Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03685331 |
| Title | HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Abramson Cancer Center at Penn Medicine |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |